126 related articles for article (PubMed ID: 7571613)
21. Assessment of beta-2-microglobulin concentration in serum and urine in rheumatoid arthritis.
Lewandowski B; Bernacka K; Kucharewicz B; Szmitkowski M; Klimiuk PA
Rocz Akad Med Bialymst; 1996; 41(2):482-91. PubMed ID: 9020562
[TBL] [Abstract][Full Text] [Related]
22. Serum C-reactive protein does not predict rheumatoid arthritis.
Aho K; Palosuo T; Knekt P; Alha P; Aromaa A; Heliövaara M
J Rheumatol; 2000 May; 27(5):1136-8. PubMed ID: 10813278
[TBL] [Abstract][Full Text] [Related]
23. [DNA--"rejoining" in lymphycytes of patients with a minifestation of rheumatoid arthritis in older age (author's transl)].
Frank O; Klein W; Kocsis F; Altmann H
Aktuelle Gerontol; 1977 Dec; 7(12):629-31. PubMed ID: 26226
[TBL] [Abstract][Full Text] [Related]
24. [Plasmatic and urinary zinc in rheumatoid arthritis (author's transl)].
Llorca G; Lejeune E; Daudens C; Bienvenu F
Pathol Biol (Paris); 1981 Feb; 29(2):73-6. PubMed ID: 7015239
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of the acid glycoprotein heterogeneity in patients with arthritis].
Domysławska I; Lewandowski B; Kita K; Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2004 Oct; 17(100):349-52. PubMed ID: 15690699
[TBL] [Abstract][Full Text] [Related]
26. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J
Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739
[TBL] [Abstract][Full Text] [Related]
27. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
Dahlqvist SR; Engstrand S; Berglin E; Johnson O
Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
[TBL] [Abstract][Full Text] [Related]
28. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.
Nielen MM; van Schaardenburg D; Reesink HW; Twisk JW; van de Stadt RJ; van der Horst-Bruinsma IE; de Gast T; Habibuw MR; Vandenbroucke JP; Dijkmans BA
Arthritis Rheum; 2004 Aug; 50(8):2423-7. PubMed ID: 15334453
[TBL] [Abstract][Full Text] [Related]
30. SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender.
Rintelen B; Haindl PM; Maktari A; Nothnagl T; Hartl E; Leeb BF
Scand J Rheumatol; 2008; 37(6):410-3. PubMed ID: 18759162
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
32. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
[TBL] [Abstract][Full Text] [Related]
34. [Reactive SH-groups in clinical practice. Methodological notes].
Ferraccioli GF; Baldini A; Ambanelli U
Acta Biomed Ateneo Parmense; 1981; 52(5):171-7. PubMed ID: 6460402
[TBL] [Abstract][Full Text] [Related]
35. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M; Bos WH; Wolbink G; Voskuyl AE; Twisk JW; Van de Stadt R; Hamann D; Dijkmans BA; Lems WF
J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
[TBL] [Abstract][Full Text] [Related]
36. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
[TBL] [Abstract][Full Text] [Related]
37. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
38. Early rheumatoid arthritis patients: relationship of age.
Papadopoulos IA; Katsimbri P; Alamanos Y; Voulgari PV; Drosos AA
Rheumatol Int; 2003 Mar; 23(2):70-4. PubMed ID: 12634939
[TBL] [Abstract][Full Text] [Related]
39. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
40. Serum biochemical markers in rheumatoid arthritis.
Pallinti V; Ganesan N; Anbazhagan M; Rajasekhar G
Indian J Biochem Biophys; 2009 Aug; 46(4):342-4. PubMed ID: 19788068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
